Skip to main content
NVDA-1.36%GOOGL-0.43%AAPL-0.40%MSFT-0.52%AMZN-0.27%TSM-0.51%AVGO-0.36%TSLA-0.84%META-0.30%WMT-0.41%BRK-B+0.01%LLY0.00%MU-0.92%JPM-0.02%AMD-2.53%XOM-0.01%V-0.01%INTC-1.76%ASMLa+0.40%JNJ-0.02%ORCL+0.45%0700.HK0.00%COST0.00%CSCO0.00%MA+0.05%1398.HK-0.22%CAT+0.03%CVX-0.02%ABBV+0.04%NFLX-0.24%LRCX-0.05%BAC-0.01%0857.HK-0.27%KO+0.01%UNH-0.03%1816.HK-27.73%AMAT-0.06%AP2d+0.38%PG-0.27%9988.HK-0.08%HSBA.L+0.42%GE-0.02%BABA-0.18%MS+0.01%HD+0.02%0005.HK-0.26%PM+0.58%AZN+0.02%GS-0.06%NVS+0.01%GBPJPY+0.89%GBPCHF+0.84%GBPUSD+0.83%EURGBP-0.81%GBPCAD+0.78%GBPAUD+0.77%NZDJPY+0.60%NZDCHF+0.54%NZDUSD+0.53%EURNZD-0.52%NZDCAD+0.49%AUDNZD-0.47%GBPTRY+0.41%GBPHKD+0.32%GBPNZD+0.29%GBPMXN-0.28%USDTHB-0.25%USDTRY+0.20%USDCNH-0.19%USDILS+0.16%AUDJPY+0.12%CADJPY+0.11%EURJPY+0.08%CADCHF+0.07%AUDCHF+0.06%SGDJPY-0.06%USDJPY+0.06%CHFSGD+0.06%AUDUSD+0.06%USDCOP-0.04%EURCAD-0.04%USDMXN+0.03%NZDSGD+0.03%USDHKD+0.03%GBPSGD+0.03%EURSGD+0.03%CHFJPY+0.03%USDCAD-0.03%EURCHF+0.03%USDSGD+0.02%EURAUD-0.02%NZDMXN+0.02%AUDCAD+0.02%USDCHF+0.02%USDZAR+0.01%EURUSD+0.01%AUDSGD+0.01%EURDKK0.00%EURCZK0.00%EURZAR0.00%USDDKK0.00%CHFSEK0.00%CHFNOK0.00%USDNOK0.00%USDPLN0.00%USDSEK0.00%AUDNOK0.00%AUDDKK0.00%EURCNH0.00%GBPZAR0.00%NOKJPY0.00%EURSEK0.00%EURPLN0.00%EURNOK0.00%EURHKD0.00%PLNJPY0.00%GAGUSD-0.33%XAGUSD-0.32%XNGUSD+0.21%USOIL-0.19%HG1-0.15%XPTUSD-0.09%XAUUSD-0.04%GAUUSD-0.04%UKOIL0.00%W10.00%S10.00%C10.00%BTCUSD-0.10%BTCUSDT+1.91%ETHUSD+0.27%USDTUSD-0.01%BNBUSD-0.13%BNBUSDT+3.01%XRPUSD-0.13%SOLUSD-0.19%TRXUSDT+0.10%DOGEUSD-0.16%ZECUSDT-0.06%ADAUSDT+0.10%ADAUSD-0.18%BCHUSDT+0.01%XMRUSDT+0.47%LINKUSD+0.28%XLMUSDT-17.58%TONUSD-0.67%XLMUSD-0.08%LTCUSD+0.24%SUIUSD-0.26%AVAXUSDT-1.18%AVAXUSD-0.09%HBARUSDT-0.02%SUIUSDT+12.82%TONUSDT+50.80%TAOUSDT-0.03%UNIUSD-0.12%NEARUSD-0.99%DOTUSDT-0.20%UNIUSDT+11.19%NEARUSDT+23.76%PEPEUSD+9970218.40%ETCUSD-0.06%ICPUSDT+0.18%AAVEUSD-0.24%ETCUSDT+6.60%ONDOUSDT+0.12%ATOMUSDT+0.23%JUPUSDT-0.09%WLDUSDT-0.32%ARBUSDT-0.55%PENGUUSDT+99398.68%INJUSDT+0.18%FETUSDT+0.24%STXUSDT-0.54%SEIUSDT-1.01%TIAUSDT-0.78%IMXUSDT-0.82%GRTUSDT+0.54%NVDA-1.36%GOOGL-0.43%AAPL-0.40%MSFT-0.52%AMZN-0.27%TSM-0.51%AVGO-0.36%TSLA-0.84%META-0.30%WMT-0.41%BRK-B+0.01%LLY0.00%MU-0.92%JPM-0.02%AMD-2.53%XOM-0.01%V-0.01%INTC-1.76%ASMLa+0.40%JNJ-0.02%ORCL+0.45%0700.HK0.00%COST0.00%CSCO0.00%MA+0.05%1398.HK-0.22%CAT+0.03%CVX-0.02%ABBV+0.04%NFLX-0.24%LRCX-0.05%BAC-0.01%0857.HK-0.27%KO+0.01%UNH-0.03%1816.HK-27.73%AMAT-0.06%AP2d+0.38%PG-0.27%9988.HK-0.08%HSBA.L+0.42%GE-0.02%BABA-0.18%MS+0.01%HD+0.02%0005.HK-0.26%PM+0.58%AZN+0.02%GS-0.06%NVS+0.01%GBPJPY+0.89%GBPCHF+0.84%GBPUSD+0.83%EURGBP-0.81%GBPCAD+0.78%GBPAUD+0.77%NZDJPY+0.60%NZDCHF+0.54%NZDUSD+0.53%EURNZD-0.52%NZDCAD+0.49%AUDNZD-0.47%GBPTRY+0.41%GBPHKD+0.32%GBPNZD+0.29%GBPMXN-0.28%USDTHB-0.25%USDTRY+0.20%USDCNH-0.19%USDILS+0.16%AUDJPY+0.12%CADJPY+0.11%EURJPY+0.08%CADCHF+0.07%AUDCHF+0.06%SGDJPY-0.06%USDJPY+0.06%CHFSGD+0.06%AUDUSD+0.06%USDCOP-0.04%EURCAD-0.04%USDMXN+0.03%NZDSGD+0.03%USDHKD+0.03%GBPSGD+0.03%EURSGD+0.03%CHFJPY+0.03%USDCAD-0.03%EURCHF+0.03%USDSGD+0.02%EURAUD-0.02%NZDMXN+0.02%AUDCAD+0.02%USDCHF+0.02%USDZAR+0.01%EURUSD+0.01%AUDSGD+0.01%EURDKK0.00%EURCZK0.00%EURZAR0.00%USDDKK0.00%CHFSEK0.00%CHFNOK0.00%USDNOK0.00%USDPLN0.00%USDSEK0.00%AUDNOK0.00%AUDDKK0.00%EURCNH0.00%GBPZAR0.00%NOKJPY0.00%EURSEK0.00%EURPLN0.00%EURNOK0.00%EURHKD0.00%PLNJPY0.00%GAGUSD-0.33%XAGUSD-0.32%XNGUSD+0.21%USOIL-0.19%HG1-0.15%XPTUSD-0.09%XAUUSD-0.04%GAUUSD-0.04%UKOIL0.00%W10.00%S10.00%C10.00%BTCUSD-0.10%BTCUSDT+1.91%ETHUSD+0.27%USDTUSD-0.01%BNBUSD-0.13%BNBUSDT+3.01%XRPUSD-0.13%SOLUSD-0.19%TRXUSDT+0.10%DOGEUSD-0.16%ZECUSDT-0.06%ADAUSDT+0.10%ADAUSD-0.18%BCHUSDT+0.01%XMRUSDT+0.47%LINKUSD+0.28%XLMUSDT-17.58%TONUSD-0.67%XLMUSD-0.08%LTCUSD+0.24%SUIUSD-0.26%AVAXUSDT-1.18%AVAXUSD-0.09%HBARUSDT-0.02%SUIUSDT+12.82%TONUSDT+50.80%TAOUSDT-0.03%UNIUSD-0.12%NEARUSD-0.99%DOTUSDT-0.20%UNIUSDT+11.19%NEARUSDT+23.76%PEPEUSD+9970218.40%ETCUSD-0.06%ICPUSDT+0.18%AAVEUSD-0.24%ETCUSDT+6.60%ONDOUSDT+0.12%ATOMUSDT+0.23%JUPUSDT-0.09%WLDUSDT-0.32%ARBUSDT-0.55%PENGUUSDT+99398.68%INJUSDT+0.18%FETUSDT+0.24%STXUSDT-0.54%SEIUSDT-1.01%TIAUSDT-0.78%IMXUSDT-0.82%GRTUSDT+0.54%
REGN
Big Pharma sector graphic highlighting trials, deal approvals, ratings and guidance shifts

Big Pharma Updates: Trials, Deals and Ratings

Major drugmakers report trial wins, upgrades, deal approvals and fresh guidance — market impacts ahead.

April 27, 2026

6 min read

Regeneron outlines multi‑indication C5 strategy

Regeneron positions an RNA‑plus‑antibody combo to unlock multibillion markets; gMG near‑term focus, PNH readout due Q4.

Apr 25, 2026

5 min read

Institutions Shift Positions in Major Blue-Chip Stocks

Portfolio reshuffling boosts insurers and biotech; analysts back health names while P&G shows investor uncertainty.

Apr 17, 2026

5 min read

Amgen Rides Renewed GLP-1 Obesity Momentum

Amgen (AMGN) is now being treated in positioning as an emerging GLP-1 obesity and diabetes play, with investors increasingly framing the stock around its obesity pipeline rather than only its legacy...

Apr 9, 2026

1 min read

Biotech ETFs Flash Classic Reversal Signal

Biotech is emerging as a leadership pocket, with SPDR S&P Biotech ETF (XBI) and Direxion Daily S&P Biotech Bull 3x Shares (LABU) showing notable relative strength into a session where both surged...

Apr 1, 2026

2 min read

Japan clears Dupixent for bullous pemphigoid

Sanofi's Dupixent wins Japanese nod for rare blistering disease after strong Phase 2/3 results; Q1 memo out.

Mar 24, 2026

4 min read

Goldman’s Top Healthcare Picks Gain Fresh Catalysts

Clinical wins and analyst upgrades spark renewed momentum across big pharma and biotech stocks.

Mar 15, 2026

4 min read

Institutions Boost Stakes in Regeneron

Mixed institutional flows reshape Regeneron momentum after a stronger quarter and upgraded outlook.

Mar 15, 2026

4 min read

Institutional Moves in Major U.S. Equities

Institutional reallocations and exec stock sales prompt analysts to keep conservative stances.

Mar 12, 2026

4 min read

2025 Valuation Insights: Spotify, Aker BP, and Key Growth Stocks

Spotify's growth shines amid valuation risks; Aker BP's gains face premium multiples in mixed market outlook.

Dec 7, 2025

5 min read